Schizophrenia |
Schizoid personality disorder; Schizotypal personality disorder |
Clinical Trial: Online Family Support and Education for Schizophrenia
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to evaluate the benefits of providing families of schizophrenia patients the opportunity to interact with each other using the Internet.
| Condition | Treatment or Intervention |
|---|---|
| Schizophrenia Schizoaffective Disorder | Behavior: Family Psychoeducational Program |
MedlinePlus related topics: Mental Health; Schizophrenia
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Expected Total Enrollment: 72
Study start: March 2001
Although psychoeducational programs for schizophrenia can reduce patient relapse rates and reduce family distress, participation rates are often low. This study will provide the families of schizophrenia patients with knowledge of illness management to reduce family burden and increase perceived social support.
Relatives of patients with schizophrenia receive either 18 months of customary care or 18 months of customary care with access to the educational website for the first year. Families are provided with private, secure access to the website, which features family-to-family chat capabilities, video lectures on the management of schizophrenia, written materials on important issues in schizophrenia management, professionally facilitated online discussions of the material, and additional resource links.
Relatives have 90-minute interviews at the beginning of the project and every 6 months for 18 months. The interviews are used to assess the family member's perception of the patient's symptoms, his or her knowledge of the illness, the illness's impact on the family member, and his or her perception of the website intervention.
Patients with schizophrenia or schizoaffective disorder are also asked to complete interviews and assessments at the beginning of the project and every 3 months for 18 months. The assessments include questions about symptoms, medication compliance and side effects, hospitalizations, and social functioning.
Eligibility
Ages Eligible for Study: 18 Years - 60 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria for Patients:
- DSM-IV diagnosis of schizophrenia or schizoaffective disorder
- Stable antipsychotic medication regimen for at least 1 month
- Able to come to the West Los Angeles area for assessments
Inclusion Criteria for Relatives:
- At least 4 hours of weekly contact with patient
- Access to a computer and Internet connection; expect to stay online for the next 12 months
- Able to come to the West Los Angeles area for assessments
Location and Contact Information
California
VA Greater Los Angeles Healthcare System, Los Angeles, California, 90073, United States; Recruiting
Shannon Prudholme 310-268-3163 sprudhol@ucla.edu
Shirley M Glynn, PhD, Principal Investigator
More Information
Record last reviewed: January 2005
Last Updated: January 7, 2005
Record first received: September 19, 2002
ClinicalTrials.gov Identifier: NCT00046085
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


